Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease
Abenavoli, L.; Milic, N.; Luigiano, C.
Minerva Medica 105(2): 175
2014
ISSN/ISBN: 0026-4806 PMID: 24727882 Document Number: 673527
Document emailed within 1 workday
Related Documents
Abenavoli, L.; Luigiano, C.; Guzzi, P.H.; Milic, N.; Morace, C.; Stelitano, L.; Consolo, P.; Miraglia, S.; Fagoonee, S.; Virgilio, C.; Luzza, F.; De Lorenzo, A.; Pellicano, R. 2014: Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease Panminerva Medica 56(2): 189-193Yoshihara, H.; Sato, N.; Kubota, S.; Inoue, A.; Matsumura, T.; Hayashi, N.; Kawano, S.; Kamada, T. 1985: Serum holo and apo type activity of mitochondrial GOT in patients with alcoholic liver disease--with special reference to alcoholic fatty liver Arukoru Kenkyu to Yakubutsu Izon 20(2): 166-174
Zhu, Q.-q.; Lou, D.-j.; Si, X.-w.; Guan, L.-l.; You, Q.-y.; Yu, Z.-m.; Zhang, A.-z.; Li, D. 2010: Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease Zhonghua Nei Ke Za Zhi 49(4): 305-308
Tahan, V.; Canbakan, B.; Balci, H.; Dane, F.; Akin, H.; Can, G.; Hatemi, I.; Olgac, V.; Sonsuz, A.; Ozbay, G.; Yurdakul, I.; Senturk, H. 2008: Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk Hepato-Gastroenterology 55(85): 1433-1438
Darmawan, G.; Hamijoyo, L.; Hasan, I. 2017: Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis Acta Medica Indonesiana 49(2): 136-147
Chu, C.-J.; Lu, R.-H.; Wang, S.-S.; Chang, F.-Y.; Lin, S.-Y.; Yang, C.-Y.; Lin, H.-C.; Chang, C.-Y.; Wu, M.-Y.; Lee, S.-D. 2007: Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease Hepato-Gastroenterology 54(79): 2045-2048
Ishii, K.-a.; Takamura, T. 2016: Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition Clinical Calcium 26(3): 363-367
Aller, R.; De Luis, D.A.; Fernandez, L.; Calle, F.; Velayos, B.; Izaola, O.; Gonzalez Sagrado, M.; Conde, R.; Gonzalez, J.M. 2009: Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease European Review for Medical and Pharmacological Sciences 13(5): 357-364
Hossain, I.A.; Faruque, M.O.; Akter, S.; Bhuiyan, F.R.; Rahman, M.K.; Ali, L. 2016: Elevated levels of serum uric acid and insulin resistance are associated with nonalcoholic fatty liver disease among prediabetic subjects Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 37(2): 101-111
Yatsuji, S.; Hashimoto, E. 2006: Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1173-1179
Xia, S.; Lin, X.; Guo, M.; Jiang, L.; Jin, J.; Lin, X.; Ding, R.; Li, S.; Jiang, Y. 2015: An analysis of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels in patients with Crohn's disease Zhonghua Nei Ke Za Zhi 54(7): 601-606
Joos, W.; Mörl, M. 1984: Alcohol-induced organic lesions. 3. Liver damage - alcoholic fatty liver, alcoholic hepatitis, acute and chronic clinical course Fortschritte der Medizin 102(4): 79-82
Dasarathy, J.; Allampati, S.; Alexander, C.; McCullough, A. 2016: Non-alcoholic fatty liver disease: What's in our arsenal? Journal of Family Practice 65(4): 239-244
Sdiri, W.; Romdhane, H.; Mbarek, D.; Ben Abdallah, H.; Longo, S.; Abdelli, M.N.; Boujnah, M.R. 2013: Non alcoholic fatty liver disease: a new risk factor for cardiovascular disease? La Tunisie Medicale 91(3): 171-174
Björklund, J.; Laursen, T.L.; Kazankov, K.; Thomsen, K.L.; Hamilton-Dutoit, S.; Stenbøg, E.; Grønbæk, H. 2017: Non-alcoholic fatty liver disease in children and adolescents Ugeskrift for Laeger 179(27)
Fan, J.-G.; Farrell, G.C. 2009: Epidemiology of non-alcoholic fatty liver disease in China Journal of Hepatology 50(1): 204-210
Heebøll, S.; Kazankov, K.; Poulsen, M.K.ær.; Vilstrup, H.; Grønbæk, H. 2012: Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis Ugeskrift for Laeger 174(8): 488-490
Roĭtberg, G.E.; Sharkhun, O.O.; Ushakova, T.I. 2010: Non-alcoholic fatty liver disease as an atherosclerosis risk factor Eksperimental'naia i Klinicheskaia Gastroenterologiia 7: 20-24
Karoli, R.; Fatima, J.; Singh, P.Shanker.; Siddiqi, Z.; Varshney, S.; Beg, M.Sameer.; Khan, M.Ali. 2019: Association of Genetic Non-alcoholic Fatty Liver Disease with Insulin Resistance-Are we Different? Journal of the Association of Physicians of India 67(3): 34-38
Tang, W.; Mu, J.; Chen, Q.I.; Li, X.; Liu, H. 2018: The involvement and mechanism of febuxostat in non-alcoholic fatty liver disease cells Journal of Biological Regulators and Homeostatic Agents 32(3): 545-551